Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-25
2010-06-15
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S233200, C514S235500, C514S235800, C514S299000, C514S306000, C544S131000, C544S127000, C544S139000, C544S111000, C546S183000
Reexamination Certificate
active
07737141
ABSTRACT:
The present invention provides a most suitable prodrug of a cinnamide compound. The prodrug is represented by Formula (I)wherein Raand Rbeach denote a C1-6 alkyl group or the like; Xadenotes a methoxy group or a fluorine atom; Y denotes a phosphono group or the like; and A denotes a cyclic lactam derivative.
REFERENCES:
patent: 4910200 (1990-03-01), Curtze et al.
patent: 5281626 (1994-01-01), Oinuma et al.
patent: 5563162 (1996-10-01), Oku et al.
patent: 5985856 (1999-11-01), Stella et al.
patent: 6235728 (2001-05-01), Golik et al.
patent: 6306870 (2001-10-01), Bombrun et al.
patent: 7053087 (2006-05-01), Beatch et al.
patent: 7138414 (2006-11-01), Schoenafinger et al.
patent: 7300936 (2007-11-01), Parker et al.
patent: 7314940 (2008-01-01), Graczyk et al.
patent: 7618960 (2009-11-01), Kimura et al.
patent: 7667041 (2010-02-01), Kimura et al.
patent: 2001/0051642 (2001-12-01), Ahn
patent: 2002/0128263 (2002-09-01), Mutel et al.
patent: 2003/0195201 (2003-10-01), Bo et al.
patent: 2003/0208082 (2003-11-01), Mutel et al.
patent: 2003/0225070 (2003-12-01), Mutel et al.
patent: 2004/0034096 (2004-02-01), Jolidon et al.
patent: 2004/0038969 (2004-02-01), Doherty et al.
patent: 2004/0063770 (2004-04-01), Ahn et al.
patent: 2004/0087798 (2004-05-01), Yamada
patent: 2004/0127494 (2004-07-01), Parker et al.
patent: 2004/0127555 (2004-07-01), Snow et al.
patent: 2004/0152743 (2004-08-01), Schoenafinger et al.
patent: 2004/0192743 (2004-09-01), Mjalli et al.
patent: 2004/0235864 (2004-11-01), Graczyk et al.
patent: 2005/0070538 (2005-03-01), Cheng et al.
patent: 2005/0131043 (2005-06-01), Mutel et al.
patent: 2005/0187277 (2005-08-01), Mjalli et al.
patent: 2006/0004013 (2006-01-01), Kimura et al.
patent: 2007/0117798 (2007-05-01), Kimura et al.
patent: 2007/0117839 (2007-05-01), Kimura et al.
patent: 2007/0219181 (2007-09-01), Kimura et al.
patent: 2008/0070902 (2008-03-01), Kimura et al.
patent: 2008/0085894 (2008-04-01), Parker et al.
patent: 2008/0096892 (2008-04-01), Cheng et al.
patent: 2008/0280948 (2008-11-01), Baumann et al.
patent: 2009/0048213 (2009-02-01), Kimura et al.
patent: 2009/0048448 (2009-02-01), Kushida et al.
patent: 2009/0203916 (2009-08-01), Kushida et al.
patent: 2009/0270623 (2009-10-01), Shimomura et al.
patent: 3 541 716 (1987-05-01), None
patent: 0 219 756 (1987-04-01), None
patent: 1 264 820 (2002-12-01), None
patent: 0 973 768 (2003-07-01), None
patent: 1 757 591 (2007-02-01), None
patent: 1 808 432 (2007-07-01), None
patent: 1 953 151 (2008-08-01), None
patent: 1 953 158 (2008-08-01), None
patent: P 2006 3920 (2006-05-01), None
patent: P-20084571 (2008-12-01), None
patent: 3-206042 (1991-09-01), None
patent: 8-283219 (1996-10-01), None
patent: 10-510512 (1998-10-01), None
patent: 11-228548 (1999-08-01), None
patent: 3176365 (2001-04-01), None
patent: 2001-508767 (2001-07-01), None
patent: 2001-527083 (2001-12-01), None
patent: 2003-206280 (2003-07-01), None
patent: 2004-531519 (2004-10-01), None
patent: 2005-518371 (2005-06-01), None
patent: 2005-526807 (2005-09-01), None
patent: 2005-531596 (2005-10-01), None
patent: 2005-533092 (2005-11-01), None
patent: 7-2780 (2005-12-01), None
patent: 2006-502247 (2006-01-01), None
patent: 2007-504282 (2007-03-01), None
patent: 2001126135 (2003-07-01), None
patent: WO-91/12237 (1991-08-01), None
patent: WO-96/10559 (1996-04-01), None
patent: WO-97/43287 (1997-11-01), None
patent: WO-98/03166 (1998-01-01), None
patent: WO-98-24785 (1998-06-01), None
patent: WO-00/07993 (2000-02-01), None
patent: WO-00/50391 (2000-08-01), None
patent: WO-00/51981 (2000-09-01), None
patent: WO-01/68585 (2001-09-01), None
patent: WO-01/81312 (2001-11-01), None
patent: WO-03/053912 (2003-07-01), None
patent: WO-03/082292 (2003-10-01), None
patent: WO-03/101927 (2003-12-01), None
patent: WO-2004/007429 (2004-01-01), None
patent: WO-2004/007455 (2004-01-01), None
patent: WO-2005/020921 (2005-03-01), None
patent: WO-2005/063754 (2005-07-01), None
patent: WO-2005/115990 (2005-08-01), None
patent: WO-2006/046575 (2006-05-01), None
patent: WO-2006/112550 (2006-10-01), None
patent: WO-2007/034282 (2007-03-01), None
patent: WO-2007/060810 (2007-05-01), None
patent: WO-2007/102580 (2007-09-01), None
patent: WO-2008/013213 (2008-01-01), None
patent: WO-2008/097538 (2008-08-01), None
patent: WO-2008/137139 (2008-11-01), None
patent: WO-2008/156580 (2008-12-01), None
patent: WO-2009/020580 (2009-02-01), None
Official Action dated Jul. 4, 2008, which issued in corresponding Russian Patent Application No. 2006146070.
Official Action issued on Nov. 14, 2008, in corresponding Russian Patent Application No. 2006146070.
T. A. Comery, The Journal of Neuroscience, Sep. 28, 2005, 25(39): 8898-8902.
T. A. Comery et al., Society for Neuroscience Annual Meeting (2003), Abstracts, Program No. 525.21.
Official Action issued Jan. 22, 2010, in Peruvian Patent Application No. 001480-2006.
Office Action issued Jan. 19, 2010, in copending U.S. Appl. No. 11/596,723.
J. G. Varnes et al., Bioorganic & Medicinal Chemistry Letters, 14 (2004) 1645-1649.
H. Stark et al., Pharmazie 52 (1997), vol. 6, pp. 419-423.
M. Kajbaf et al., Journal of Chromatography, 575 (1992) 75-85.
S. L. Marcus, Cancer Research, 45, 112-115, Jan. 1995.
H. L. Yale, J. Med. Chem., 1966, 9(1), 42-46.
S. M. Catalano et al., “The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimer's Disease,” Current Topics in Medicinal Chemistry, vol. 6, 597-608 (2006).
Search Report issued May 27, 2009, in connection with Georgia Patent Application No. AP 2006 010709 (with English translation).
Yuesong Gong et al.; Proceeding National Academy of Science, vol. 100, No. 18, pp. 10417-10422, Sep. 2, 2003.
Christoph Hock et al.; Neuron, vol. 38, No. 4, pp. 547-554, May 22, 2003.
Joseph T. Jarrett et al.; Biochemistry; vol. 32, No. 18, pp. 4693-4697, May 11, 1993.
George G. Glenner et al.; Biochemical and Biophysical Research Communications; vol. 120, No. 3, pp. 885-890, May 16, 1984.
Colin L. Masters et al.; Proceeding National Academy of Science; vol. 82, No. 12, pp. 4245-4249, Jun. 1985.
Gunnar K. Gouras et al.; American Journal of Pathology, vol. 156, No. 1, pp. 15-20, Jan. 2000.
D. Scheuner et al.; Nature Medicine, vol. 2, No. 8, pp. 864-870, Aug. 1996.
Mark S. Forman et al.; The Journal of Biological Chemistry; vol. 272, No. 51, pp. 32247-32253, Dec. 19, 1997.
Mark S. Shearman et al.; Biochemistry; vol. 39, No. 30, pp. 8698-8704, 2000.
Huw D. Lewis et al.; Biochemistry, vol. 42, No. 24, pp. 7580-7586, 2003.
Thomas A. Lanz et al., The Journal of Pharmacology and Experimental Therapeutics; vol. 39, No. 1, pp. 49-55, 2004.
Gwendolyn T. Wong et al.; The Journal of Biological Chemistry, vol. 279, No. 13, pp. 12876-12882, Mar. 26, 2004.
John P. Blass; Journal of Neuroscience Research, vol. 66, No. 1, pp. 851-856, 2001.
Genevieve Evin et al.; NeuroReport; vol. 13, No. 5, pp. 719-723, Apr. 16, 2002.
Osamu Yasuhara et al.; Neuroscience Letters, vol. 171, Nos. 1 and 2, pp. 63-66, 1994.
Jan T. Teller et al.; Nature Medicine, vol. 2, No. 1, pp. 93-95, Jan. 1996.
Takahiko Tokuda et al.; Annals Neurology, vol. 41, No. 2, pp. 271-273, Feb. 1997.
Yorihide Hayashi et al.; Brain Research; vol. 789, No. 2, pp. 307-314, 1998.
Helene Barelli et al.; Molecular Medicine, vol. 3, No. 10, pp. 695-707, Oct. 1997.
Michael E. Calhoun et al.; Proceeding National Academy of Science, vol. 96, No. 24, pp. 14088-14093, Nov. 23, 1999.
B. Dermaut et al.; Brain, vol. 124, No. 12, pp. 2383-2392, 2001.
P. Cras et al.; Acta Neuropathol, vol. 96, No. 3, pp. 253-260, 1998.
Martin C. Herzig et al.; Nature Neuroscience, vol. 7, No. 9, pp. 954-960, Sep. 2004.
Sjoerd G. Van Duinen et al.; Proceeding National Academy of Science, vol. 84, No. 16, pp. 5991-5994, Aug. 1987.
Efrat Levy et al.; Science, vol. 248, No. 4959, pp. 1124-1126, 1990.
Simon M. Laws et al.; Neurobiology of Aging, vol. 23, No. 1, pp. 55-58, 2002.
E. Vaucher et al.; Experimental Neurology, vol. 175, No. 2, pp. 398-406, 2002.
Dave Morgan et al.; Nature, vol. 408, No. 6815, pp. 982-985, Dec. 2000.
Paula M. Moran et al.; Proceeding National Academy of Science, vol
Ito Koichi
Kaneko Toshihiko
Kawano Koki
Kimura Teiji
Kitazawa Noritaka
Anderson Rebecca L
Birch & Stewart Kolasch & Birch, LLP
Eisai R&D Management Co., Ltd.
LandOfFree
Prodrug of cinnamide compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prodrug of cinnamide compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prodrug of cinnamide compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4153632